Recent advancements in microspheres mediated targeted delivery for therapeutic interventions in osteoarthritis

Ayush Rohila1, Rahul Shukla1

  • 1Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research-Raebareli, Lucknow, India.

PubMed

Insights

Microspheres offer a promising solution for osteoarthritis (OA) by improving drug delivery to joints. This review explores how these advanced delivery systems can enhance therapeutic efficacy for OA management.

Area of Science:

  • Biomaterials Science
  • Drug Delivery Systems
  • Rheumatology

Background:

  • Osteoarthritis (OA) affects 240 million globally, with current treatments only managing symptoms, not disease progression.
  • Articular cartilage's poor vasculature hinders drug bioavailability and leads to rapid elimination, complicating effective OA treatment.
  • Existing OA drugs, including KGN and IL-1 receptor antagonists, face formulation challenges impacting their therapeutic potential.

Purpose of the Study:

  • To review the potential of microspheres as a drug delivery system for effective osteoarthritis (OA) management.
  • To explore various biomaterials used in microspheres for delivering drugs and biologicals for OA.
  • To highlight the role of microspheres in improving therapeutic efficacy through targeted delivery strategies.

Main Methods:

  • Comprehensive literature review of microsphere-based therapies for OA.
  • Analysis of distinct biomaterials utilized in microsphere formulations.
  • Examination of different drug delivery routes and targeting strategies for OA intervention.
  • Review of clinical trials related to microsphere applications in OA over recent decades.

Main Results:

  • Microspheres demonstrate excellent physicochemical properties suitable for OA intervention.
  • Targeting strategies using microspheres can significantly improve therapeutic efficacy in OA management.
  • Various biomaterials are being explored for microsphere development to overcome current drug delivery limitations.

Conclusions:

  • Microspheres represent a viable platform for advancing OA treatment beyond symptom management.
  • Optimized microsphere formulations can enhance drug bioavailability and prolong residence time in afflicted joints.
  • Further research and clinical trials are warranted to fully realize the therapeutic potential of microspheres in OA.